Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06158607 · ClinicalTrials.gov registry record · NA

Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders

A NA study of Substance Use, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06158607: Recruiting NA study of Substance Use, sponsored by The University of Texas Health Science Center, Houston.

NCT06158607 is a NA study of Substance Use that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06158607, a NA study of Substance Use, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence

Primary Outcome

Filling the PrEP prescription and taking at least one dose of the medication by two weeks following their visit with the PrEP provider

Conditions Studied

Substance Use

Interventions

  • BEHAVIORAL Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders
  • OTHER Standard of care treatment

Study Locations (1)

Texas

  • Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-06-07
Est. Completion 2025-05-30
Phase NA
The University of Texas Health Science Center, Houston

732 total trials

What NCT06158607 shows while recruiting

NCT06158607 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders is the first listed.

NCT06158607 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06158607 about?

NCT06158607 is a clinical study titled "Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders". The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase...

What is the current status of trial NCT06158607?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-07. Estimated completion is 2025-05-30.

What conditions does trial NCT06158607 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT06158607?

The interventions under investigation include: Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders (BEHAVIORAL), Standard of care treatment (OTHER).

Who is sponsoring clinical trial NCT06158607?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06158607 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06158607's enrollment target sits among peer trials

60 71st of 88 higher than 15 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06158607

Source: ClinicalTrials.gov NCT06158607, the US trial registry maintained by the National Library of Medicine. NCT06158607 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.